HECTD2-AS1
gene geneOn this page
Summary
HECTD2-AS1 (HECTD2 antisense RNA 1, HGNC:48679) is a long non-coding RNA gene on chromosome 10q23.32.
At a glance
- Clinical variants (ClinVar): 3 total
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48679 |
| Approved symbol | HECTD2-AS1 |
| Name | HECTD2 antisense RNA 1 |
| Location | 10q23.32 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Entrez | 100188947 |
| RNAcentral | URS000075B789 — lncRNA, 1038 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Top tissues by expression
0 total, by Bgee expression score (0-100, higher = more expressed):
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chr10q23
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3523 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:91410574:GCG:G | donor_gain | 1.0000 |
| 10:91410576:GGTA:G | donor_loss | 1.0000 |
| 10:91410577:G:GG | donor_gain | 1.0000 |
| 10:91410578:T:G | donor_loss | 1.0000 |
| 10:91425279:AG:A | acceptor_gain | 1.0000 |
| 10:91425280:GG:G | acceptor_gain | 1.0000 |
| 10:91425406:GAATG:G | donor_gain | 1.0000 |
| 10:91425407:AATGG:A | donor_loss | 1.0000 |
| 10:91425408:ATGG:A | donor_loss | 1.0000 |
| 10:91425409:TGG:T | donor_loss | 1.0000 |
| 10:91425410:GGTAA:G | donor_loss | 1.0000 |
| 10:91425411:G:T | donor_loss | 1.0000 |
| 10:91425412:T:A | donor_loss | 1.0000 |
| 10:91460416:A:AG | acceptor_gain | 1.0000 |
| 10:91460417:T:G | acceptor_gain | 1.0000 |
| 10:91460418:A:AG | acceptor_gain | 1.0000 |
| 10:91460419:C:G | acceptor_gain | 1.0000 |
| 10:91460423:A:AG | acceptor_gain | 1.0000 |
| 10:91460423:ACAGT:A | acceptor_gain | 1.0000 |
| 10:91460424:CAGTG:C | acceptor_gain | 1.0000 |
| 10:91460425:A:AG | acceptor_gain | 1.0000 |
| 10:91460425:AGT:A | acceptor_gain | 1.0000 |
| 10:91460425:AGTGA:A | acceptor_gain | 1.0000 |
| 10:91460426:G:GA | acceptor_gain | 1.0000 |
| 10:91460426:GT:G | acceptor_gain | 1.0000 |
| 10:91460426:GTG:G | acceptor_gain | 1.0000 |
| 10:91460426:GTGA:G | acceptor_gain | 1.0000 |
| 10:91460426:GTGAG:G | acceptor_gain | 1.0000 |
| 10:91460561:TTTCA:T | donor_gain | 1.0000 |
| 10:91460562:TTCA:T | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000000543 (10:91556098 C>T), RS1000005287 (10:91330825 TA>T,TAA), RS1000010439 (10:91349979 A>T), RS1000015057 (10:91562855 T>C), RS1000018277 (10:91420328 G>A), RS1000019188 (10:91480561 A>G), RS1000025891 (10:91379758 G>A,C), RS1000031444 (10:91490771 G>A,C), RS1000043372 (10:91446237 G>A,T), RS1000053866 (10:91565566 T>C,G), RS1000096098 (10:91591065 C>T), RS1000132761 (10:91574890 G>A), RS1000146243 (10:91467531 G>A,T), RS1000152813 (10:91387961 G>A), RS1000214003 (10:91543940 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| benzo(e)pyrene | increases methylation | 1 |
| fipronil | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| DEET | affects cotreatment, decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.